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Background: Ovarian hyper stimulation syndrome (OHSS) is an iatrogenic complication associated with fertility
drugs. It is characterized by increased vascular permeability and substantial fluid shift with accumulation in the
body cavity. The pathogenesis of OHSS remains obscure, and no definitive treatments are currently available.
Results: Using western blot and short-circuit current (Isc) techniques, we investigate the potential coactions of
analysis in cystic fibrosis transmembrane conductance regulator (CFTR) and aquaporin 1 (AQP1) on the hyper
permeability of body cavity peritoneal epithelial cells in the pathogenesis of OHSS. The rats develop OHSS
symptoms, with the up regulation of both CFTR and AQP1 expression and enhanced CFTR channel activity in
peritoneal epithelial cells, can also be mimicked by administration of estrogen, alone in ovariectomized rats.
Administration of progesterone suppresses CFTR activity, OHSS symptoms as well as CFTR and AQP1 expression.
Besides, AQP1 inhibitor, HgCl2, can suppress CFTR channel activity. Therefore, antisera against CFTR or AQP1 to
OHSS animals may result in alleviation of the symptom.
Conclusion: This study confirms the coactions of CFTR and AQP1 play a critical role in the development and
progression of increased peritoneal epithelial permeability in severe OHSS. These findings may provide grounds for
ameliorating assisted reproduction treatment strategy to reduce the risk of OHSS in in vitro fertilization (IVF).
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Ovarian hyper stimulation syndrome (OHSS) is a severe
complication of ovulation induction in in vitro
fertilization (IVF) treatment. The incidence of OHSS
occurs in about 0.1–4% of ovulation induction treat-
ments [1], is increasing around the world through the
expansion of infertility treatments. OHSS is character-
ized by massive cystic enlargement of the ovaries asso-
ciated with third space fluid shift. This can result in the
formation of ascites and pleural effusion in severe
conditions due to increased peritoneal epithelial perme-
ability [2]. Severe OHSS can be accompanied by* Correspondence: LiLing63035@sina.com
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reproduction in any medium, provided the orhypercoagulability, thromboembolic phenomena, adult
respiratory distress syndrome, and even death. Although
this syndrome has been identified for a long time, the
exact mechanism of OHSS induction is not clear. An
increased epithelial permeability is the initial change
leading to OHSS [3]. Many cytokines and vasoactive and
angiogenic factors, such as vascular endothelial growth
factor (VEGF), have been implicated as major mediators
of the pathogenesis of capillary leakage and endothelial
damage in OHSS [4-7].
Fluid effluxing across epithelial cells is followed by ion
movements. Ion movements play a crucial role in the
movement of water across epithelial cells, as water fluc-
tuation depends on the opening and closing of aquapor-
ins (AQPs) actively and inactively transported as it
follows ion movements according to osmotic gradientsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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OHSS, may be a consequence of abnormal ion transport
across the epithelial cells. Several pathological condi-
tions, such as cholera-induced diarrhea, in which there
is massive fluid efflux of ion and water across epithelial
membranes, are mediated by altered expression and
function of transepithelial ion channels, particularly cys-
tic fibrosis transmembrane conductance regulator
(CFTR) [9]. Cystic fibrosis is manifested by mutations in
CFTR [10], the most common lethal genetic disease in
Caucasians, with a hallmark defect in epithelial electro-
lyte and fluid transport throughout the body [11]. A pre-
vious study only focused on the reproductive system
effect of CFTR on OHSS, but did not investigate CFTR
in the peritoneal epithelial cells [12]. Meanwhile, in the
process of fluid effusion, water efflux involves a water
(AQP1) pathway by which ion and other osmotic gradi-
ents drive water movement [8]. So the coactions of ion
channels and AQP1 such as CFTR [12] are important in
the process of fluid effusion.
CFTR is expressed in most epithelial cells including
the airways and gastrointestinal and reproductive tracts

























































Figure 1 Induction of OHSS rat model and upregulation of CFTR and
given different combinations of gonadotropins showed significantly enhan
compared with the controls (A, B and C; n = 5) with corresponding enhan
PMSG- and hCG-induced OHSS rat peritoneal epithelial cells. The Pixel Valu
AQP1: Control 150834, PMSG/hCG 348630; The Pixel Value for β-Actin: Con
control).ovarian hormones [15,16], upregulated by estrogen, and
down regulated by progesterone [17]. Cyclic changes in
CFTR expression and its channel activity have been cor-
related with cyclic changes in uterine fluid volume
[18,19]. Meanwhile, the water channel AQP1 is
expressed strongly throughout microvascular endothelia
except the central nervous system, such as in the kid-
neys, lungs, skins, secretory glands, skeletal muscles,
pleura and peritoneum [20,21]. AQP1 is involved in fluid
transport [20,21], and facilitates water movement from
capillaries into the peritoneal cavity [22]. Its expression
is also regulated by ovarian hormones [23,24]. It has also
been well established that estrogen levels are highly ele-
vated during ovarian hyper stimulation, with excessively
high levels observed in patients with OHSS [25,26]. We,
therefore, hypothesized that increased estrogen levels
during ovarian hyper stimulation may lead to upregu-
lated CFTR and AQP1 expression and channel activity,
resulting in the elevated epithelial secretory activity. The
most prominent feature of OHSS is marked with ascites
or even pleural effusion almost always associated with
the administration of human chorionic gonadotropin

































AQP1 expression in peritoneal epithelial cells. Hyperstimulated rats
ced WT increase, ascites volumes and pleural effusion volumes
cement of CFTR and AQP1 protein expression by western blot in
e for CFTR: Control 265488, PMSG/hCG 765729; The Pixel Value for
trol 980058, PMSG/hCG 971052 (D). ***P< 0.001 (compared with the
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OHSS development.
Results
Up regulation of CFTR and AQP1 expression in peritoneal
epithelial cells
Combinations of gonadotropins including HMG, FSH,
or PMSG in conjunction with hCG were used to trigger
OHSS. In our study, rat hyper stimulation was defined
by the observation of either fluid accumulation in
the peritoneal cavity and thorax, or increased body
weight (WT) in contrast to the saline-treated control rats
(Figure 1 A-C). Body weight was measured, and ascites
was collected by performing a lower midline incision and
completely draining the intra-abdominal fluid into a
flask. After ascites was collected, the diaphragm was cut
off by scissors and pleural effusion volume was also col-
lected. The effusion volumes were then measured with a
1-ml tuberculin syringe respectively. Most prominently,
the increase of ascites volume and pleural effusion vol-
ume in the hyper stimulated rats was significantly differ-


























Figure 2 Estrogen upregulates CFTR and AQP1 expression in peritone
concentrations in OHSS were significantly different from control rats at bot
(n = 6, 6, and 6 for diestrus, estrus, and OHSS, respectively). Comparison of
treatment with progesterone or estrogen for 5 d (n = 5/group), showing si
the control). Western blot results showed downregulation of CFTR and AQ
estrogen in peritoneal epithelial cells of ovariectomized rats. The Pixel Valu
885290, Estrogen+Progesterone 363422; The Pixel Value for AQP1: ovariecto
+Progesterone 160054; The Pixel Value for β-Actin: ovariectomy 708508, Prowas associated with elevated CFTR and AQP1 expression
in peritoneal epithelial cells (Figure 1 D).
Estrogen upregulated CFTR and AQP1 expression and
induced OHSS in rats
Estrogen levels were measured in our PMSG/hCG-
induced OHSS rats and those control rats at both es-
trous and diestrous stages of the estrous cycle. More
than 5-fold increase in estrogen levels was found in the
OHSS rats compared with that in the control (Figure 2
A). We also found that hyper stimulation did
not produce OHSS symptom in ovariectomized rats.
However, treatment of ovariectomized rats with estro-
gen (10 μg/kgd), but not progesterone (25 mg/d) for
5 d, induced WT increase compared with ovariecto-
mized control (P < 0.0001; Figure 2 B) and increased
CFTR and AQP1 expression in peritoneal epithelial
cells (Figure 2 C) similar to the OHSS rat model. Fur-
thermore, progesterone suppressed the action of estro-
gen on OHSS induction and CFTR and AQP1
expression up regulation (Figure 2 B and C). These

























al epithelial cells and induces OHSS in rats. Serum estrogen
h estrous and diestrous stages of the estrous cycle (A). ***P< 0.001
increased WT of rat 30 d after ovariectomy (control) and after
gnificantly increased WT by estrogen (B). ***P< 0.001 (compared with
P1 expression by progesterone and upregulation expression by
e for CFTR: ovariectomy 260546, Progesterone 202730, Estrogen
my 186484, Progesterone 101092, Estrogen 877020, Estrogen
gesterone 707448, Estrogen 707982, Estrogen+Progesterone 709654 (C).
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tion of CFTR and AQP1 leading to OHSS.Effect of OHSS on peritoneal epithelial CFTR channel
activity in rats
We compared CFTR activity between freshly isolated
peritoneal epithelial cells of normal and OHSS rats by
Isc measurement. In the presence of an epithelial so-
dium channel blocker, amiloride (to exclude a possible
contribution of Na+ absorption to the current observed),
the forskolin-induced Isc from the peritoneal epithelia of
OHSS rats (PMSG plus hCG) was substantially increased
compared with that in untreated controls at the dies-
trous or estrous stages of the sexual cycle (Figure 3).
The cAMP-dependent Isc could be blocked by a CFTR
specific inhibitor-172 (Calbiochem, La Jolla, CA USA;
Figure 3 A-D), confirming that the observed cAMP-
activated Isc reflects CFTR channel activity. The results
showed that CFTR channel activity was enhanced in
OHSS.Effect of estrogen and progesterone on the peritoneal
epithelial CFTR channel activity
The effect of exogenously administrated estrogen and
progesterone for 5 d on peritoneum CFTR channel ac-
tivity was examined. Isc measurements showed that
forskolin-induced or CFTR-mediated Isc in estrogen-
treated peritoneum (Figure 4 B and D) was significantly
higher than that in progesterone-treated ones (Figure 4
A and D). Besides, progesterone suppressed estrogen
induced CFTR-mediated Isc in estrogen-treated periton-
eum (Figure 4 C and D).A
C
Figure 3 Effect of OHSS on peritoneal epithelial CFTR channel activity
presence of an epithelial Na+ channel blocker, amiloride (10 μM), showed a
peritoneal epithelial cells (C) compared with the controls at diestrous (A) a
(n = 4/group, compared with the diestrus).Progesterone downregulated CFTR and AQP1 expression
and suppressed OHSS rats
Progesterone treatment (25 mg/ratd) of PMSG/hCG-
induced OHSS rats significantly reduced WT increase,
ascites volume and pleural effusion volume (Figure 5 A-
C). Progesterone treatment of OHSS rats also
significantly reduced CFTR and AQP1 protein expres-
sion (Figure 5 D). Besides, a selective progesterone an-
tagonist, mifepristone irrigation significantly reduced the
reverse of progesterone to OHSS symptoms of rats as
well as CFTR and AQP1 expression reduction in peri-
toneal epithelial cells (Figure 5 A-D). It may be the rea-
son why progesterone was found to significantly lower
the incidence of OHSS in IVF cycles in a few clinical
situations for luteal support during assisted reproductive
technology (ART) [28-30].
Coaction of the peritoneal epithelial CFTR and AQP1
channel activity in the development of OHSS
We found that AQP1 inhibitor (HgCl2) could suppress
the CFTR activity in the freshly isolated peritoneal epi-
thelial cells of OHSS rats by the short circuit current
(Isc) measurement. For the OHSS rats (PMSG plus
hCG), in the presence of an AQP1 inhibitor, HgCl2 (to
block water exocrine), the forskolin-induced Isc from
the peritoneal epithelial cells of OHSS rats (PMSG plus
hCG) was substantially decreased compared with that in
untreated controls of the OHSS rats (Figure 6 A-C). Fur-
thermore, treatment of noncycling PMSG-/hCG-induced
OHSS rats (to exclude any cyclic influence) with 300 μl
CFTR antiserum (1:100 dilution, vol/vol, in buffer;
Zymed Laboratories) or 400μl AQP1 antiserum (1:100





























. CFTR-mediated peritoneum anion secretion measured by Isc in the
n elevated forskolin (10 μM) response in PMSG-/hCG-induced OHSS




























Figure 4 Effect of estrogen and progesterone on the peritoneal epithelial CFTR channel activity. Progesterone treatment (25 mg/drat) of
female rats for 5 d did not induce CFTR-mediated Isc in the peritoneal epithelial cells (A), but estrogen treatment (10 μg/kg body weightd) did
(B). Besides, progesterone treatment suppressed estrogen induced CFTR-mediated Isc (C). Statistical analyses of forskolin-activated CFTR-mediated
Isc response showed significant CFTR activity in the peritoneum of estrogen-treated rats (C). ***P< 0.001 (n = 12).
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resulted in the elimination of body WT increase, ascites
volumes and pleural effusion volumes (Figure 6 D-F).
Discussion
In addition to being a chloride channel, CFTR, may
function as a regulator of other channels, including
aquaporin water channels (channels that allow rapid
flow of water across epithelial membranes) and epithelial
sodium channels. Enhancement of aquaporin channel
activity [31] and suppression of epithelial sodium
channel-mediated absorptive activity [32] that results in
net increases in electrolyte and fluid secretion may also
contribute to the pathogenesis of OHSS.
To test this hypothesis, we developed the OHSS rat
model by using several combinations of gonadotropins
as previously described [33]. There was a marked in-
crease in fluid accumulation in the peritoneal cavity and
pleural cavity (Figure 1 B and C). Therefore, the
increased body WT in the hyperstimulated rats was sig-
nificantly different from those in the controls (Figure 1
A). Enhanced CFTR and AQP1 expression in body cav-
ity peritoneal epithelial cells was observed in the OHSS
rats (Figure 1 D). Thus, up-regulated CFTR and AQP1
expression in peritoneal epithelial cells is correlated with
the fluid accumulation observed in the body cavity of
OHSS animals. It has been well documented that OHSS
patients have high plasma estrogen levels [26]. It ispossible that hyper stimulation of ovaries leads to high
production and release of estrogen, which is responsible
for the upregulation of CFTR and AQP1 observed. This
may explain why OHSS may not occur or may become
severe despite high estrogen levels in some individuals
who could have CFTR mutations and defective CFTR
function.
Estrogen levels had been monitored in the induced
OHSS rats as well as in the controls at both estrous and
diestrous stages of the estrous cycle. The results showed
that estrogen levels increased over 6-fold in the OHSS
rats compared with that in the controls (Figure 2 A),
which is consistent with other OHSS animal models
[33]. The relationship between elevation of estrogen
alone and OHSS had been investigated by developing of
OHSS symptoms in ovariectomized rats. It confirmed
that hyper stimulation did not produce OHSS symptoms
in these ovariectomized rats unless treated with estro-
gen, but not progesterone, for 5 days (Figure 2 B). Fur-
thermore, progesterone suppressed estrogen induced
OHSS symptom as well as CFTR and AQP1 expression
upregulation (Figure 2 B and C). Exogenous estrogen
induced WT increase as well as CFTR and AQP1
expression upregulation in ovariectomized rats, similar
to those in the OHSS rat model without ovariectomy
(Figure 2 B and C). It should be noted that although es-
trogen drastically increased CFTR and AQP1 expression,















































































Figure 5 Effect of progesterone on the expression of CFTR and AQP1 expression in peritoneal epithelial cells and OHSS symptoms in
rats. Statistical comparison of WT increase (A), ascites volume (B), and pleural effusion volume (C) in PMSG-/hCG-induced OHSS rats and OHSS
rats [treated with progesterone, 25 mg/drat; or treated with both progesterone (25 mg/drat) and mifepristone (diluted in corn oil, 10mg/drat,
irrigation daily), n = 5/group]. *P < 0.05, **P < 0.01, *** P < 0.001. Western blot results showed that expression of CFTR and AQP1 proteins in
peritoneal epithelial cells were suppressed by progesterone in the OHSS rats. The Pixel Value for CFTR: OHSS 1005806, OHSS+progesterone
223260, OHSS+progesterone+mifepristone 394564; The Pixel Value for AQP1: OHSS 424325, OHSS+progesterone 183016, OHSS+progesterone
+mifepristone 248076; The Pixel Value for β-Actin: OHSS 821654, OHSS+progesterone 824855, OHSS+progesterone+mifepristone 823090 (D).
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results obtained in ovary-intact animals showing upregu-
lation and downregulation of CFTR by estrogen and
progesterone, respectively [17]. OHSS symptoms and
CFTR upregulation in peritoneal epithelial cells were
also observed in ovary-intact rats treated with high levels
of estrogen, but not progesterone (Figure 2 B and C).
The serum level of exogenously administrated estrogen
was similar to the estrogen levels in OHSS rats (Figure 2
B and C). These results suggest that the ovarian sex hor-
mone, estrogen, but not progesterone, is responsible for
the upregulation of CFTR and AQP1 leading to OHSS.
These results support the clinical observation that OHSS
rarely develops in individuals undergoing ovarian hyper
stimulation in the absence of high estrogen levels [26].
To confirm that up regulation of CFTR indeed leads
to enhancement of its channel activity, from where ex-
cessive epithelial fluid secretion derives, we compared
functional CFTR activity between freshly isolated peri-
toneal epithelial cells of normal and OHSS rats by theIsc measurement [34]. To exclude a possible contribu-
tion of Na+ absorption to the current, we used amilor-
ide, an epithelial sodium channel blocker. The results
revealed that the forskolin-induced Isc from the periton-
eal epithelial cells of OHSS rats was substantially
increased compared with that of untreated controls at
the diestrous or estrous stage of the sexual cycle (CFTR
is known to be minimally and maximally expressed, re-
spectively). The cAMP-dependent Isc could be blocked
by a specific CFTR inhibitor-172 (Figure 3 A-D), which
has been demonstrated to inhibit CFTR-mediated, chol-
era toxin-induced fluid secretion [35]. It confirmed that
the observed cAMP-activated Isc reflects CFTR channel
activity. The effect of exogenously administrated estro-
gen and progesterone for 5 d on peritoneal CFTR chan-
nel activity was also examined. Isc measurements
showed that forskolin-induced or CFTR-mediated Isc in
estrogen-treated peritoneum was significantly higher
than that of progesterone-treated (Figure 4 A and B).









































































































Figure 6 Coactions of CFTR and AQP1 in the excessive fluid transport in OHSS. The HgCl2 pre-treatment (30μ M) suppressed CFTR-
mediated Isc in the peritoneal epithelial cells (A, B and C), showing Coaction of CFTR and AQP1 activity in the peritoneal epithelial cells. **P< 0.01
(n = 6). Noncycling PMSG-/hCG-induced OHSS rats treated with 300 μl CFTR antiserum or 400μl AQP1 antiserum (1:100 dilution, vol/vol, in buffer)
significantly reduced WT increase (D), ascites volumes (E) and pleural volumes (F) compared with the heat-inactivated normal rat serum
(NRS)-treated controls. *P < 0.05 (n = 6).
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it appears that up regulation of CFTR and AQP1 due to
elevated estrogen may be responsible for the excessive
fluid transport and accumulation in OHSS. Therefore, it
may be possible to alleviate OHSS symptoms through
suppressing CFTR or AQP1 expression or through sup-
pressing CFTR or AQP1 function. To validate thishypothesis, we first used progesterone, as it was shown
to suppress CFTR expression in previous studies [17]
and in the present study as well. Indeed, progesterone
treatment of OHSS rats also eliminated peritoneal and
pleural fluid accumulation and significantly reduced
CFTR and AQP1 protein expression (Figure 5 A-D).
The progesterone selective progesterone antagonist,
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gesterone (Figure 5 A-D). Interestingly, progesterone
has been used in a few clinical situations for luteal sup-
port during ART, in which it was found to significantly
lower the incidence of OHSS in IVF cycles. However
no explanation for such an effect was published [28-
30]. In summary, progesterone may suppress the ex-
pression of CFTR and AQP1 to alleviate the symptom
of OHSS.
To confirm the coactions of CFTR and AQP1 in the
pathogenesis of OHSS, the cAMP-dependent Isc was
used to measure CFTR channel activity affected by
AQP1. The results showed that the cAMP-dependent
Isc could also be reduced by an AQP1 inhibitor, HgCl2
(Figure 6 A-C), which has been demonstrated to inhibit
AQP1-mediated water transport [36]. This confirmed
that AQP1 can affect CFTR channel activity. Further-
more, treatment of PMSG-/hCG-induced OHSS rats
injected with 300 μl CFTR antiserum resulted in the
elimination of the body WT increase about 3.23 g,
the peritoneal fluid accumulation about 2.69 ml and the
pleural fluid accumulation about 0.58 ml. Injection of
300 μl AQP1 antiserum resulted in the elimination of
the body WT increase about 3.23 g, the peritoneal fluid
accumulation about 2.56 ml and the pleural fluid accu-
mulation about 0.64 ml (Figure 6 D-F). The ability to al-
leviate OHSS symptoms through interfering with CFTR
or AQP1 function confirmed a critical role of the coac-
tions of CFTR and AQP1 in OHSS pathogenesis. It also
suggested that these treatments may be a preventive
measure for OHSS during ART.
In this study, we demonstrated that up regulation of
both CFTR and AQP1 by either excessive estrogen or
ovarian hyper stimulation leads to the development of
OHSS symptoms in rodents. Considering the observed
high levels of estrogen, exceeding normal physiological
levels, in patients undergoing ovarian hyper stimulation
[25,26] and regulation of CFTR and AQP1 expression by
ovarian hormones in humans [14], the present findings
in OHSS rodent models are of strong clinical relevance,
suggesting the coactions of CFTR and AQP1 in the
pathogenesis of OHSS. OHSS appears to be the result of
abnormally up regulating CFTR as well as AQP1. This
leads to excessive fluid shift and accumulation in the
peritoneal cavity and pleural cavity, which can be life
threatening. It is because that fluid transport throughout
the body due to water effusion following ion
transportation.
Conclusions
Taken together, this study confirms the coactions of
CFTR and AQP1 in regulating body electrolyte and fluid
secretion. An abnormality in either expression or func-
tion, could result in lethal conditions, as seen in OHSS.Methods
Animals
Prior approval of the experimental protocols was
obtained from the local ethics committee at Zhengzhou
University for use of animals in experiments. The Spra-
gue–Dawley (S-D) rats were used in this study. Animals
were maintained in the Laboratory Animal Service Cen-
ter of Zhengzhou University before experiments and
were kept in a temperature-controlled room with a
12L:12D cycle and with food and water ad libitum. All
animal experiments were conducted in accordance with
the university Laboratory Animals Service Center’s
guidelines on animal experimentation.
Ovariectomy
The animals were 13 weeks of age (when rats reach sex-
ual maturation), weighing about 250–300 g. General
anesthesia was administered using intraperitoneal (IP)
injection of a mixture of 2% xylazine hydrochloride (10
mg/kg) (Alfasan, Woerden, Holland) and ketamine
hydrochloride (80 mg/kg) (Alfasan). With the use of
sharp dissecting scissors, both oviducts were exposed,
one at a time, after careful dissection and bilateral ovi-
ductal ligation were performed, and ovaries were
removed. The uterine horns were gently put back into
the peritoneal cavity. The muscle layers were approxi-
mated with absorbable suture, skin incisions were closed
using surgical clips, and adequate postoperative care was
given. Rats were kept for at least 30 d to recover and ad-
just before additional experiments.
OHSS induction
Female S-D rats at 13 weeks old were divided into four
groups (n=5/group). All rats were weighed before the
experiment. To prepare the OHSS model, the rats are
stimulated with human menopausal gonadotropin
(HMG, Serono Laboratories, Aubonne, Switzerland), fol-
licle stimulating hormone (FSH, Organon NV, Oss, The
Netherlands), or pregnant mares’ serum gonadotrophin
(PMSG, Sigma-Aldrich Corp., St. Louis, MO, USA) in
conjunction with hCG (Organon NV) as previously
reported [33]. Gonadotropins were administered by IP
injections. PMSG (300 IU/kg body weight), HMG (75
IU/ratd), and FSH (75 IU/ratd) were injected for 4 d
consecutively; on the fifth day, rats received 300 IU
hCG/rat. Control animals received phosphate buffered
saline (PBS) for the same period. Serum concentrations
of estradiol is also increased.
Western blot analysis
Tissue samples, peritoenal biopsy, were lysed with modi-
fied RIPA buffer (50 mM Tris–HCl, pH 7.4; 150 mM
NaCl, 1% NP40, 0.25% Na-deoxycholate, 1 mM EDTA)
supplemented with 1mM PMSF to inhibit proteolytic
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amounts of protein (20-30μg) were separated on 10-
12% sodium dodecyl sulphate polyacrylamide gel elec-
trophoresis (SDS-PAGE) and transferred to Hybond-
ECL nitrocellulose membranes (Amersham, USA).
Membrane was blocked using 4% skimmed milk and
then incubated with anti-CFTR antibody (Zymed La-
boratories, San Fransisco, CA, USA), β-Actin (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) and anti-
AQP1 antibody (Santa Cruz Biotechnology). The blots
were incubated with HRP-conjugated goat anti-rabbit
secondary antibodies (Santa Cruz Biotechnology) and
were visualized by Enhanced Chemiluminescence
(ECL) (Amersham Biosciences, USA) following light
sensitive films (Fuji, Japan) development. Integrated
density values were calculated using Alpha Imager
3400 (Alpha InnoTech, USA). The actual values of the
western blot bands were quantified using MetaMorph
image analysis software (Universal Imaging Corpor-
ation, USA). And the quantities of the protein were
valued by pixel value. All experiments were repeated at
least three times and the representative results were
presented.Short-circuit current (Isc) measurement
Isc measurement has previously been described [34]. In
brief, freshly removed parietal peritoneum from which
the muscular layers had been removed were clamped
vertically between two halves of the Ussing chamber.
The peritoneal epithelial cells were bathed on both sides
with Krebs-Henseleit solution that was maintained at 37
C. The Krebs-Henseleit solution had the following com-
position: 117 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2,
1.2 mM MgCl2, 24.8 mM NaHCO3, 1.2 mM KH2PO4,
and 11.1 mM glucose and it was bubbled with 95% O2
and 5% CO2 to maintain the pH at 7.4. Drugs were
added directly to the apical or basolateral side of the epi-
thelial cells. The transepithelial potential differences
exhibited by the epithelial cells were measured by the
Ag/AgCl electrodes (World Precision Instruments, Sara-
sota, FL, USA) connected to a preamplifier, which was
connected to a voltage clamp amplifier (DVC 1000,
World Precision Instruments). The change in Isc was
defined as the maximal rise in Isc after agonist stimula-
tion and was normalized as current change per unit area
of the peritoneal epithelial cells (microamperes per
square centimeter).Hormonal measurement
Serum estrogen concentrations were measured using an
electro-chemiluminescence immunoassay by means of
the Elecsys Estradiol 11 kit with the automated Elecsys
Immunoanalyzer (Roche, Mannheim, Germany).Statistical analysis
Data are presented as the means ± SEM. Multiple com-
parisons and differences between groups were analyzed
using the one-way ANOVA test, and paired data were
analyzed by unpaired t test. P < 0.05 (two-tailed) was
considered statistically significant. Analyses were carried
out with PRISM (GraphPad, Inc., San Diego, CA, USA).
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